WEKO3
アイテム
{"_buckets": {"deposit": "5904919c-a8f4-4845-a13f-70421b40ce7d"}, "_deposit": {"id": "20166", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "20166"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00020166", "sets": ["456", "1162"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "A Combination Chemotherapy Consisting of Adriamycin, Vincristine, Etoposide and Cyclophosphamide (AVEC therapy) for Small Cell Lung Cancer"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1993-05", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "450", "bibliographicPageStart": "444", "bibliographicVolumeNumber": "107", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Twenty patients with small cell lung cancer (SCLC), 11 limited disease (LD) and 9 had extensive disease (ED), were treated with a combination chemotherapy consisting of ADM (40mg/m^2, i.v., day 1), VCR (1mg/m^2, i.v., day 1), ETP (60mg/m^2, i.v., day 1~5) and CPA (600mg/m^2, i.v., day 1) (AVEC therapy) at 4week intervals. The overall response rate and the complete response (CR) rate were 100% (11/11) and 36% (4/11) in LD cases, and 78% (7/9) and 0% (0/9) in ED cases, respectively. The median response duration were 9 months in LD cases and 2 months in ED cases. The median survival time of LD, ED and all cases were 13, 9 and 13 months, respectively. The over 3 years survival rate was 20% (4/20). The major toxicity was myelosupression, although it was well tolerated. These results suggest that the AVEC therapy is effective for SCLC.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "124714", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nakajima, Yoshiaki"}]}, {"nameIdentifiers": [{"nameIdentifier": "124715", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Hatakeyama, Shinobu"}]}, {"nameIdentifiers": [{"nameIdentifier": "124716", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Suzuki, Eiichi"}]}, {"nameIdentifiers": [{"nameIdentifier": "124717", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nagai, Akihiko"}]}, {"nameIdentifiers": [{"nameIdentifier": "124718", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kioi, Satoru"}]}, {"nameIdentifiers": [{"nameIdentifier": "124719", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Arakawa, Masaaki"}]}, {"nameIdentifiers": [{"nameIdentifier": "124720", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tawaraya, Kouzou"}]}, {"nameIdentifiers": [{"nameIdentifier": "124721", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Haraguchi, Michihiko"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "中島, 喜章"}], "nameIdentifiers": [{"nameIdentifier": "124706", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "畠山, 忍"}], "nameIdentifiers": [{"nameIdentifier": "124707", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木, 栄一"}], "nameIdentifiers": [{"nameIdentifier": "124708", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "永井, 明彦"}], "nameIdentifiers": [{"nameIdentifier": "124709", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "来生, 哲"}], "nameIdentifiers": [{"nameIdentifier": "124710", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "荒川, 正昭"}], "nameIdentifiers": [{"nameIdentifier": "124711", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "俵谷, 幸蔵"}], "nameIdentifiers": [{"nameIdentifier": "124712", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "原口, 通比古"}], "nameIdentifiers": [{"nameIdentifier": "124713", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "107(5)_444-450.pdf", "filesize": [{"value": "1.4 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1400000.0, "url": {"label": "107(5)_444-450.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/20166/files/107(5)_444-450.pdf"}, "version_id": "950df9a2-bd19-4bf8-97d9-6a3262a0d526"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Small Cell Lung Cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Combination Chemotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Adriamycin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Vincristine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Etoposide", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cyclophosphamide", "subitem_subject_scheme": "Other"}, {"subitem_subject": "肺小細胞癌", "subitem_subject_scheme": "Other"}, {"subitem_subject": "多剤併用科学療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "アドリアマイシン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ビンクリスチン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "エトポシド", "subitem_subject_scheme": "Other"}, {"subitem_subject": "サイクロフォスファマイド", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法"}, {"subitem_title": "肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1162"], "permalink_uri": "http://hdl.handle.net/10191/37400", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-02-02"}, "publish_date": "2016-02-02", "publish_status": "0", "recid": "20166", "relation": {}, "relation_version_is_last": true, "title": ["肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法"], "weko_shared_id": null}
肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法
http://hdl.handle.net/10191/37400
http://hdl.handle.net/10191/3740090f6b385-8d70-4347-8242-bc8a11f657d4
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-02-02 | |||||
タイトル | ||||||
タイトル | 肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 肺小細胞癌に対するAdriamycin, Vincristine, Etoposide, Cyclophosphamide (AVEC)併用療法 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Small Cell Lung Cancer | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Combination Chemotherapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Adriamycin | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Vincristine | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Etoposide | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Cyclophosphamide | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 肺小細胞癌 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 多剤併用科学療法 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | アドリアマイシン | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | ビンクリスチン | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | エトポシド | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | サイクロフォスファマイド | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | A Combination Chemotherapy Consisting of Adriamycin, Vincristine, Etoposide and Cyclophosphamide (AVEC therapy) for Small Cell Lung Cancer | |||||
著者 |
中島, 喜章
× 中島, 喜章× 畠山, 忍× 鈴木, 栄一× 永井, 明彦× 来生, 哲× 荒川, 正昭× 俵谷, 幸蔵× 原口, 通比古 |
|||||
著者別名 | ||||||
識別子 | 124714 | |||||
識別子Scheme | WEKO | |||||
姓名 | Nakajima, Yoshiaki | |||||
著者別名 | ||||||
識別子 | 124715 | |||||
識別子Scheme | WEKO | |||||
姓名 | Hatakeyama, Shinobu | |||||
著者別名 | ||||||
識別子 | 124716 | |||||
識別子Scheme | WEKO | |||||
姓名 | Suzuki, Eiichi | |||||
著者別名 | ||||||
識別子 | 124717 | |||||
識別子Scheme | WEKO | |||||
姓名 | Nagai, Akihiko | |||||
著者別名 | ||||||
識別子 | 124718 | |||||
識別子Scheme | WEKO | |||||
姓名 | Kioi, Satoru | |||||
著者別名 | ||||||
識別子 | 124719 | |||||
識別子Scheme | WEKO | |||||
姓名 | Arakawa, Masaaki | |||||
著者別名 | ||||||
識別子 | 124720 | |||||
識別子Scheme | WEKO | |||||
姓名 | Tawaraya, Kouzou | |||||
著者別名 | ||||||
識別子 | 124721 | |||||
識別子Scheme | WEKO | |||||
姓名 | Haraguchi, Michihiko | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Twenty patients with small cell lung cancer (SCLC), 11 limited disease (LD) and 9 had extensive disease (ED), were treated with a combination chemotherapy consisting of ADM (40mg/m^2, i.v., day 1), VCR (1mg/m^2, i.v., day 1), ETP (60mg/m^2, i.v., day 1~5) and CPA (600mg/m^2, i.v., day 1) (AVEC therapy) at 4week intervals. The overall response rate and the complete response (CR) rate were 100% (11/11) and 36% (4/11) in LD cases, and 78% (7/9) and 0% (0/9) in ED cases, respectively. The median response duration were 9 months in LD cases and 2 months in ED cases. The median survival time of LD, ED and all cases were 13, 9 and 13 months, respectively. The over 3 years survival rate was 20% (4/20). The major toxicity was myelosupression, although it was well tolerated. These results suggest that the AVEC therapy is effective for SCLC. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 107, 号 5, p. 444-450, 発行日 1993-05 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |